XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Unaudited Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
Common Stock
Additional Paid in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 25,372 $ 104,078,968 $ (48,921) $ (65,318,360) $ 38,737,059
Balance (in Shares) at Dec. 31, 2021 25,371,781        
Stock-based compensation 1,177,702 1,177,702
Foreign currency translation adjustment 47,234 47,234
Net loss (8,376,002) (8,376,002)
Balance at Mar. 31, 2022 $ 25,372 105,256,670 (1,687) (73,694,362) 31,585,993
Balance (in Shares) at Mar. 31, 2022 25,371,781        
Balance at Dec. 31, 2021 $ 25,372 104,078,968 (48,921) (65,318,360) 38,737,059
Balance (in Shares) at Dec. 31, 2021 25,371,781        
Net loss         (24,396,828)
Balance at Sep. 30, 2022 $ 25,518 107,922,543 (210,347) (89,715,188) 18,022,526
Balance (in Shares) at Sep. 30, 2022 25,518,084        
Balance at Mar. 31, 2022 $ 25,372 105,256,670 (1,687) (73,694,362) 31,585,993
Balance (in Shares) at Mar. 31, 2022 25,371,781        
Issuance of common stock for stock option exercises $ 2 10,183 10,185
Issuance of common stock for stock option exercises (in Shares) 2,037        
Stock-based compensation 1,195,081 1,195,081
Foreign currency translation adjustment (105,434) (105,434)
Net loss (8,746,325) (8,746,325)
Balance at Jun. 30, 2022 $ 25,374 106,461,934 (107,121) (82,440,687) 23,939,500
Balance (in Shares) at Jun. 30, 2022 25,373,818        
Sale of common stock through ATM $ 104 404,451 404,555
Sale of common stock through ATM (in Shares) 104,011        
Issuance of common stock for stock option exercises $ 40 100,597 100,637
Issuance of common stock for stock option exercises (in Shares) 40,255        
Stock-based compensation   955,561     955,561
Foreign currency translation adjustment (103,226) (103,226)
Net loss (7,274,501) (7,274,501)
Balance at Sep. 30, 2022 $ 25,518 107,922,543 (210,347) (89,715,188) 18,022,526
Balance (in Shares) at Sep. 30, 2022 25,518,084        
Balance at Dec. 31, 2022 $ 36,193 120,070,983 (139,295) (97,088,422) $ 22,879,459
Balance (in Shares) at Dec. 31, 2022 36,193,085       36,193,085
Stock-based compensation 751,821 $ 751,821
Costs related to ATM (17,920) (17,920)
Foreign currency translation adjustment (18,669) (18,669)
Net loss (7,051,367) (7,051,367)
Balance at Mar. 31, 2023 $ 36,193 120,804,884 (157,964) (104,139,789) 16,543,324
Balance (in Shares) at Mar. 31, 2023 36,193,085        
Balance at Dec. 31, 2022 $ 36,193 120,070,983 (139,295) (97,088,422) $ 22,879,459
Balance (in Shares) at Dec. 31, 2022 36,193,085       36,193,085
Net loss         $ (16,480,817)
Balance at Sep. 30, 2023 $ 59,134 127,404,746 (203,712) (113,569,239) $ 13,690,929
Balance (in Shares) at Sep. 30, 2023 59,133,574       59,133,574
Balance at Mar. 31, 2023 $ 36,193 120,804,884 (157,964) (104,139,789) $ 16,543,324
Balance (in Shares) at Mar. 31, 2023 36,193,085        
Stock-based compensation 825,719 825,719
Costs related to ATM (59,229) (59,229)
Foreign currency translation adjustment (7,566) (7,566)
Net loss (5,020,206) (5,020,206)
Balance at Jun. 30, 2023 $ 36,193 121,571,374 (165,530) (109,159,995) 12,282,042
Balance (in Shares) at Jun. 30, 2023 36,193,085        
Sale of common stock in public offering, net of offering costs $ 22,881 5,041,841 5,064,722
Sale of common stock in public offering, net of offering costs (in Shares) 22,880,400        
Sale of common stock through ATM $ 60 25,212 25,272
Sale of common stock through ATM (in Shares) 60,089        
Stock-based compensation 766,319 766,319
Foreign currency translation adjustment (38,182) (38,182)
Net loss (4,409,244) (4,409,244)
Balance at Sep. 30, 2023 $ 59,134 $ 127,404,746 $ (203,712) $ (113,569,239) $ 13,690,929
Balance (in Shares) at Sep. 30, 2023 59,133,574       59,133,574